Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (851-860 of 1,142) with videos related to

Pageof 115
Sort By:
Human Psychopharmacology|February 1, 2013
Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Tristram A Lett, et al.
Psychiatry Research|June 24, 2014
No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Clement C Zai, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 5, 1997
Setting standards and defining quality of performance in the validation of a standardized-patient examination formatC J Rosebraugh, A J Speer, D J Solomon, et al.
Life Sciences|May 18, 1999
Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatumH Lee, F I Tarazi, M Chakos, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humansS A Lieberman, J Bukar, S A Chen, et al.
American Journal of Medical Genetics|December 15, 1994
Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophreniaP Seeman, C Ulpian, G Chouinard, et al.
Schizophrenia Research|September 17, 2019
An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate <sup>1</sup>H MRSLawrence S Kegeles, Adam Ciarleglio, Pablo León-Ortiz, et al.
Pharmacogenomics|March 15, 2014
Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Nabilah I Chowdhury, et al.
Plos One|July 14, 2012
The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injuryPeter H Lapchak, Antonis Ioannou, Poonam Rani, et al.
Human Psychopharmacology|April 27, 2024
Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesiaRuoyu Wang, Justin Y Lu, Deanna Herbert, et al.
Pageof 115

Showing results (851-860 of 1,142) with videos related to

Sort By:
Pageof 115
Human Psychopharmacology|February 1, 2013
Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Tristram A Lett, et al.
Psychiatry Research|June 24, 2014
No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Clement C Zai, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 5, 1997
Setting standards and defining quality of performance in the validation of a standardized-patient examination formatC J Rosebraugh, A J Speer, D J Solomon, et al.
Life Sciences|May 18, 1999
Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatumH Lee, F I Tarazi, M Chakos, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humansS A Lieberman, J Bukar, S A Chen, et al.
American Journal of Medical Genetics|December 15, 1994
Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophreniaP Seeman, C Ulpian, G Chouinard, et al.
Schizophrenia Research|September 17, 2019
An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate <sup>1</sup>H MRSLawrence S Kegeles, Adam Ciarleglio, Pablo León-Ortiz, et al.
Pharmacogenomics|March 15, 2014
Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Nabilah I Chowdhury, et al.
Plos One|July 14, 2012
The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injuryPeter H Lapchak, Antonis Ioannou, Poonam Rani, et al.
Human Psychopharmacology|April 27, 2024
Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesiaRuoyu Wang, Justin Y Lu, Deanna Herbert, et al.
Pageof 115